• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与新冠疫情:为何肥胖宿主如此脆弱?

Obesity and COVID-19: what makes obese host so vulnerable?

作者信息

Mohammad Sameer, Aziz Rafia, Al Mahri Saeed, Malik Shuja Shafi, Haji Esraa, Khan Altaf Husain, Khatlani Tanvir Saleem, Bouchama Abderrezak

机构信息

Experimental Medicine Department, King Abdullah International Medical Research Center/King Saud bin Abdulaziz University for Health Sciences-MNGHA, Riyadh, 11426, Saudi Arabia.

Government Medical College Baramulla, Baramulla, Kashmir, India.

出版信息

Immun Ageing. 2021 Jan 4;18(1):1. doi: 10.1186/s12979-020-00212-x.

DOI:10.1186/s12979-020-00212-x
PMID:33390183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7779330/
Abstract

The disease (COVID-19) novel coronavirus pandemic has so far infected millions resulting in the death of over a million people as of Oct 2020. More than 90% of those infected with COVID-19 show mild or no symptoms but the rest of the infected cases show severe symptoms resulting in significant mortality. Age has emerged as a major factor to predict the severity of the disease and mortality rates are significantly higher in elderly patients. Besides, patients with underlying conditions like Type 2 diabetes, cardiovascular diseases, hypertension, and cancer have an increased risk of severe disease and death due to COVID-19 infection. Obesity has emerged as a novel risk factor for hospitalization and death due to COVID-19. Several independent studies have observed that people with obesity are at a greater risk of severe disease and death due to COVID-19. Here we review the published data related to obesity and overweight to assess the possible risk and outcome in Covid-19 patients based on their body weight. Besides, we explore how the obese host provides a unique microenvironment for disease pathogenesis, resulting in increased severity of the disease and poor outcome.

摘要

截至2020年10月,新型冠状病毒(COVID-19)大流行已感染数百万人,导致100多万人死亡。超过90%的COVID-19感染者症状轻微或无症状,但其余感染者则出现严重症状,导致显著的死亡率。年龄已成为预测疾病严重程度的主要因素,老年患者的死亡率明显更高。此外,患有2型糖尿病、心血管疾病、高血压和癌症等基础疾病的患者因感染COVID-19而患重病和死亡的风险增加。肥胖已成为因COVID-19住院和死亡的一个新的风险因素。多项独立研究观察到,肥胖者因COVID-19患重病和死亡的风险更大。在此,我们回顾已发表的与肥胖和超重相关的数据,以评估COVID-19患者根据其体重可能面临的风险和预后。此外,我们探讨肥胖宿主如何为疾病发病机制提供独特的微环境,导致疾病严重程度增加和预后不良。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cf7/7780383/76aef52b0257/12979_2020_212_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cf7/7780383/b13ed015a347/12979_2020_212_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cf7/7780383/76aef52b0257/12979_2020_212_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cf7/7780383/b13ed015a347/12979_2020_212_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cf7/7780383/76aef52b0257/12979_2020_212_Fig2_HTML.jpg

相似文献

1
Obesity and COVID-19: what makes obese host so vulnerable?肥胖与新冠疫情:为何肥胖宿主如此脆弱?
Immun Ageing. 2021 Jan 4;18(1):1. doi: 10.1186/s12979-020-00212-x.
2
Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet.肥胖与新冠病毒 19 严重并发症的高风险:当两种大流行相遇时该怎么办。
J Popul Ther Clin Pharmacol. 2020 Jun 29;27(S Pt 1):e31-e36. doi: 10.15586/jptcp.v27iSP1.708.
3
From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.从流感病毒到新型冠状病毒(SARS-CoV-2)——肥胖的贡献。
Front Endocrinol (Lausanne). 2020 Oct 6;11:556962. doi: 10.3389/fendo.2020.556962. eCollection 2020.
4
Proper Management of People with Obesity during the COVID-19 Pandemic.2019冠状病毒病大流行期间肥胖人群的妥善管理
J Obes Metab Syndr. 2020 Jun 30;29(2):84-98. doi: 10.7570/jomes20056.
5
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.2019冠状病毒病患者临床特征对重症疾病的预测作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.
6
Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.墨西哥门诊和住院患者严重急性呼吸综合征冠状病毒 2 感染后生存的决定因素。
Public Health. 2020 Dec;189:66-72. doi: 10.1016/j.puhe.2020.09.014. Epub 2020 Sep 30.
7
Obesity as an Important Marker of the COVID-19 Pandemic.肥胖作为新冠疫情的一个重要标志。
Cureus. 2022 Jan 19;14(1):e21403. doi: 10.7759/cureus.21403. eCollection 2022 Jan.
8
Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19).早期抗病毒治疗有助于减轻新型冠状病毒病 (COVID-19) 患者的病情严重程度并改善预后。
J Intern Med. 2020 Jul;288(1):128-138. doi: 10.1111/joim.13063. Epub 2020 Apr 20.
9
The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea.韩国大邱市 2019 年冠状病毒病中度至重度感染合并糖尿病患者的临床特征和结局。
Diabetes Metab J. 2020 Aug;44(4):602-613. doi: 10.4093/dmj.2020.0146. Epub 2020 Aug 12.
10

引用本文的文献

1
SARS-CoV-2 mRNA vaccines confer protection in diet-induced obese mice despite altered immune cell profiles in the lung.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)信使核糖核酸(mRNA)疫苗尽管会改变肺部免疫细胞谱,但仍能在饮食诱导的肥胖小鼠中提供保护。
Sci Rep. 2025 Jul 26;15(1):27209. doi: 10.1038/s41598-025-12320-z.
2
Effect of obesity on the acute response to SARS-CoV-2 infection and development of post-acute sequelae of COVID-19 (PASC) in nonhuman primates.肥胖对非人灵长类动物感染SARS-CoV-2的急性反应及新冠病毒感染后急性后遗症(PASC)发展的影响。
PLoS Pathog. 2025 Jul 24;21(7):e1012988. doi: 10.1371/journal.ppat.1012988. eCollection 2025 Jul.
3

本文引用的文献

1
The obesity paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) cohort.肥胖悖论:来自 SMAtteo COvid-19 REgistry(SMACORE)队列的分析。
Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1920-1925. doi: 10.1016/j.numecd.2020.07.047. Epub 2020 Aug 11.
2
Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity.COVID-19 患者的抗凝血酶与死亡率之间的关联。与肥胖之间可能存在联系。
Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1914-1919. doi: 10.1016/j.numecd.2020.07.040. Epub 2020 Jul 28.
3
Male Sex, Severe Obesity, Older Age, and Chronic Kidney Disease Are Associated With COVID-19 Severity and Mortality in New York City.
Role of Galanin system and insulin resistance parameters as predictive tools for diagnosis of Long-COVID patients.
甘丙肽系统和胰岛素抵抗参数作为预测工具在长新冠患者诊断中的作用。
Biochem Biophys Rep. 2025 Jun 3;43:102068. doi: 10.1016/j.bbrep.2025.102068. eCollection 2025 Sep.
4
Associations between type III interferons, obesity and clinical severity of COVID-19.III型干扰素、肥胖与新型冠状病毒肺炎临床严重程度之间的关联。
Front Immunol. 2025 Apr 22;16:1516756. doi: 10.3389/fimmu.2025.1516756. eCollection 2025.
5
Effect of obesity on the acute response to SARS-CoV-2 infection and development of post-acute sequelae of COVID-19 (PASC) in nonhuman primates.肥胖对非人灵长类动物感染SARS-CoV-2的急性反应及新冠病毒感染后急性后遗症(PASC)发展的影响。
bioRxiv. 2025 Feb 22:2025.02.18.638792. doi: 10.1101/2025.02.18.638792.
6
The Impact of Diet Quality on COVID-19 Severity and Outcomes-A Scoping Review.饮食质量对新冠病毒疾病严重程度和转归的影响——一项范围综述
Curr Nutr Rep. 2025 Feb 1;14(1):27. doi: 10.1007/s13668-025-00618-3.
7
Impact of Obesity-Associated SARS-CoV-2 Mutations on COVID-19 Severity and Clinical Outcomes.肥胖相关的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)突变对冠状病毒病2019(COVID-19)严重程度和临床结局的影响
Viruses. 2024 Dec 30;17(1):38. doi: 10.3390/v17010038.
8
Body Mass Index and Postacute Sequelae of SARS-CoV-2 Infection in Children and Young Adults.儿童和青年人群 SARS-CoV-2 感染的体重指数与感染后后遗症。
JAMA Netw Open. 2024 Oct 1;7(10):e2441970. doi: 10.1001/jamanetworkopen.2024.41970.
9
Mendelian randomization analysis reveals causal association of anthropometric measures on sepsis risk and mortality.孟德尔随机化分析揭示了人体测量指标与脓毒症风险和死亡率之间的因果关系。
PLoS One. 2024 Sep 30;19(9):e0310898. doi: 10.1371/journal.pone.0310898. eCollection 2024.
10
Multiphase optimization strategy to establish optimal delivery of nutrition-related services in healthcare settings: A step towards clinical trial.多阶段优化策略,在医疗环境中建立最佳的营养相关服务提供:迈向临床试验的一步。
Contemp Clin Trials. 2024 Nov;146:107683. doi: 10.1016/j.cct.2024.107683. Epub 2024 Sep 3.
男性、重度肥胖、高龄以及慢性肾脏病与纽约市新冠肺炎的严重程度和死亡率相关。
Chest. 2021 Jan;159(1):112-115. doi: 10.1016/j.chest.2020.08.2065. Epub 2020 Aug 28.
4
Higher Obesity Trends Among African Americans Are Associated with Increased Mortality in Infected COVID-19 Patients Within the City of Detroit.底特律市感染新冠病毒的非裔美国人中较高的肥胖率与死亡率增加有关。
SN Compr Clin Med. 2020;2(8):1045-1047. doi: 10.1007/s42399-020-00385-y. Epub 2020 Jun 30.
5
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization.肥胖与新冠肺炎确诊患者的死亡率:来自一体化医疗保健组织的研究结果。
Ann Intern Med. 2020 Nov 17;173(10):773-781. doi: 10.7326/M20-3742. Epub 2020 Aug 12.
6
Impact of obesity on hospitalizations and mortality, due to COVID-19: A systematic review.肥胖对因 COVID-19 导致的住院和死亡的影响:一项系统评价。
Obes Res Clin Pract. 2020 Sep-Oct;14(5):398-403. doi: 10.1016/j.orcp.2020.07.005. Epub 2020 Jul 23.
7
Obesity and COVID-19: A Virchow's Triad for the 21st Century.肥胖与2019冠状病毒病:21世纪的魏尔啸三联征
Thromb Haemost. 2020 Nov;120(11):1590-1593. doi: 10.1055/s-0040-1714216. Epub 2020 Jul 17.
8
COVID-19 and obesity.新型冠状病毒肺炎与肥胖症
Minerva Gastroenterol Dietol. 2020 Dec;66(4):293-295. doi: 10.23736/S1121-421X.20.02748-8. Epub 2020 Jul 16.
9
Obesity and covid-19: the unseen risks.肥胖与新冠疫情:潜在风险
BMJ. 2020 Jul 16;370:m2823. doi: 10.1136/bmj.m2823.
10
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre.肥胖症作为住院 COVID-19 患者发生呼吸衰竭、入住重症监护病房和死亡的危险因素有多重要?来自意大利单一中心的研究结果。
Eur J Endocrinol. 2020 Oct;183(4):389-397. doi: 10.1530/EJE-20-0541.